CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma

Oral Oncology

Volumn 43, Issue 1, 2007, Pages 51-59

  Kosunen, A ^a   Pirinen, R ^a   Ropponen, K ^a   Pukkila, M ^a   Kellokoski, J ^a   Virtaniemi, J ^a   Sironen, R ^a   Juhola, M ^b   Kumpulainen, E ^a   Johansson, R ^a   Nuutinen, J ^a   Kosma, V M ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

Author keywords

CD44; MMP 9; Oral cancer; Prognosis; Squamous cell carcinoma

Indexed keywords

GELATINASE B; HERMES ANTIGEN;

ADOLESCENT; ADULT; AGED; ANTIGEN PRESENTATION; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; SCHOOL CHILD; SQUAMOUS CELL CARCINOMA; STAINING; STATISTICAL SIGNIFICANCE; TUMOR CELL; TUMOR DIFFERENTIATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; CARCINOMA, SQUAMOUS CELL; CHILD; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MOUTH NEOPLASMS; MULTIVARIATE ANALYSIS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33846517569     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2006.01.003     Document Type: Article

References (36)

1. Silverman Jr. S. Oral cancer. 5th ed. (2003), American Cancer Society
2. Bajorath J. Molecular organization, structural features, and ligand binding characteristics of CD44, a highly variable cell surface glycoprotein with multiple functions. Proteins 39 2 (2000) 103-111
3. Lesley J., Hyman R., and Kincade P.W. CD44 and its interaction with extracellular matrix. Adv Immunol 54 (1993) 271-335
4. Rudzki Z., and Jothy S. CD44 and the adhesion of neoplastic cells. Mol Pathol 50 2 (1997) 57-71
5. Kunishi M., Kayada Y., and Yoshiga K. Down-regulated expression of CD44 variant 6 in oral squamous cell carcinomas and its relationship to regional lymph node metastasis. Int J Oral Maxillofac Surg 26 4 (1997) 280-283
6. Ue T., Yokozaki H., Kagai K., et al. Reduced expression of the CD44 variant exons in oral squamous cell carcinoma and its relationship to metastasis. J Oral Pathol Med 27 5 (1998) 197-201
7. Oliveira D.T., Sherriff M., and Odell E.W. Expression of CD44 variant exons by primary and metastatic oral squamous carcinomas. J Oral Pathol Med 27 7 (1998) 303-307
8. Stoll C., Baretton G., Soost F., et al. Prognostic importance of the expression of CD44 splice variants in oral squamous cell carcinomas. Oral Oncol 35 5 (1999) 484-489
9. Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 200 4 (2003) 448-464
10. Manes S., Llorente M., Lacalle R.A., et al. The matrix metalloproteinase-9 regulates the insulin- like growth factor-triggered autocrine response in DU-145 carcinoma cells. J Biol Chem 274 11 (1999) 6935-6945
11. Giannelli G., Falk-Marzillier J., Schiraldi O., et al. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 277 5323 (1997) 225-228
12. Jordan R.C., Macabeo-Ong M., Shiboski C.H., et al. Overexpression of matrix metalloproteinase-1 and -9 mRNA is associated with progression of oral dysplasia to cancer. Clin Cancer Res 10 19 (2004) 6460-6465
13. Riedel F., Gotte K., Schwalb J., et al. Expression of 92-kDa type IV collagenase correlates with angiogenic markers and poor survival in head and neck squamous cell carcinoma. Int J Oncol 17 6 (2000) 1099-1105
14. Impola U., Uitto V.J., Hietanen J., et al. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer. J Pathol 202 1 (2004) 14-22
15. Katayama A., Bandoh N., Kishibe K., et al. Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumour metastases and prognosis. Clin Cancer Res 10 2 (2004) 634-640
16. de Vicente J.C., Fresno M.F., Villalain L., et al. Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma. Oral Oncol 41 3 (2005) 283-293
17. Yu Q., and Stamenkovic I. Cell surface-localised matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumour invasion and angiogenesis. Genes Dev 14 2 (2000) 163-176
18. Head and neck tumours. In: Sobin L.H., and Wittekind C. (Eds). TNM classification of malignant tumours. 5th ed. (1997), John Wiley & Sons, Inc., New York 17-50
19. In: Shanmugaratnam K. (Ed). Histological typing of tumours of the upper respiratory tract and ear. 2nd ed. (1991), Springer-Verlag, Heidelberg
20. Yu Q., and Stamenkovic I. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev 13 1 (1999) 35-48
21. Ponta H., Sherman L., and Herrlich P.A. CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 4 1 (2003) 33-45
22. Hirvikoski P., Tammi R., Kumpulainen E., et al. Irregular expression of hyaluronan and its CD44 receptor is associated with metastatic phenotype in laryngeal squamous cell carcinoma. Virchows Arch 434 1 (1999) 37-44
23. Bahar R., Kunishi M., Kayada Y., et al. CD44 variant 6 (CD44v6) expression as a progression marker in benign, premalignant and malignant oral epithelial tissues. Int J Oral Maxillofac Surg 26 6 (1997) 443-446
24. Coussens L.M., Tinkle C.L., Hanahan D., et al. MMP-9 supplied by bone marrow derived cells contributes to skin carcinogenesis. Cell 103 3 (2000) 481-490
25. Tokumaru Y., Fujii M., Otani Y., et al. Activation of matrix metalloproteinase-2 in head and neck squamous cell carcinoma: studies of clinical samples and in vitro cell lines co-cultured with fibroblasts. Cancer Lett 150 1 (2000) 15-21
26. Spessotto P., Rossi F.M., Degan M., et al. Hyaluronan-CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9. J Cell Biol 158 6 (2002) 1133-1144
27. Assimakopoulos D., Kolettas E., Patrikakos G., et al. The role of CD44 in the development and prognosis of head and neck squamous cell carcinomas. Histol Histopathol 17 4 (2002) 1269-1281
28. Carinci F., Stabellini G., Calvitti M., et al. CD44 as prognostic factor in oral and oropharyngeal squamous cell carcinoma. J Craniofac Surg 13 1 (2002) 85-89
29. Bankfalvi A., Krassort M., Buchwalow I.B., et al. Gains and losses of adhesion molecules (CD44, E-cadherin, and beta-catenin) during oral carcinogenesis and tumour progression. J Pathol 198 3 (2002) 343-351
30. Kosunen A., Ropponen K., Kellokoski J., et al. Reduced expression of hyaluronan is a strong indicator of poor survival in oral squamous cell carcinoma. Oral Oncol 40 3 (2004) 257-263
31. Piffko J., Bankfalvi A., Klauke K., et al. Unaltered strong immunohistochemical expression of CD44-v6 and -v5 isoforms during development and progression of oral squamous cell carcinomas. J Oral Pathol Med 25 9 (1996) 502-506
32. Kuo M.Y., Cheng S.J., Chen H.M., et al. Expression of CD44s, CD44v5, CD44v6 and CD44v7-8 in betel quid chewing-associated oral premalignant lesions and squamous cell carcinomas in Taiwan. Oral Pathol Med 27 9 (1998) 428-433
33. Masuda M., Kuratomi Y., Shiratsuchi H., et al. Decreased CD44H expression in early-stage tongue carcinoma associates with late nodal metastases following interstitial brachytherapy. Head Neck 22 7 (2000) 662-665
34. Sato S., Miyauchi M., Takekoshi T., et al. Reduced expression of CD44 variant 9 is related to lymph node metastasis and poor survival in squamous cell carcinoma of tongue. Oral Oncol 36 6 (2000) 545-549
35. Fonseca I., Pereira T., Rosa-Santos J., et al. Expression of CD44 isoforms in squamous cell carcinoma of the border of the tongue: a correlation with histological grade, pattern of stromal invasion, and cell differentiation. J Surg Oncol 76 2 (2001) 115-120
36. Gonzalez-Moles M.A., Bravo M., Ruiz-Avila I., et al. Adhesion molecule CD44 as a prognostic factor in tongue cancer. Anticancer Res 23 6D (2003) 5197-5202